Pharma

Your Article Summary

See Latest Articles

Physio-Control Receives FDA 510(K) Clearance For LIFEPAK 15 Monitor/Defibrillator
Medtronic, 03/27/09

Physio-Control, Inc., a wholly owned subsidiary of Medtronic, Inc., announced it has received clearance from the U.S. Food and Drug Administration (FDA) to market the LIFEPAK 15 monitor/defibrillator within the United States. “With the LIFEPAK 15 monitor/defibrillator, Physio-Control is delivering on its commitment to provide innovative, reliable and durable equipment to emergency personnel so they can focus on the most important task at hand — saving lives,” said Brian Webster, president of Physio-Control. “This industry was built on the innovations delivered by Physio-Control and the LIFEPAK 15 monitor continues to define the new standard for emergency care products.”

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Advisory Committee Supports Use of Aztreonam for Inhalation Solution for Patients with Cystic Fibrosis
Gilead, 12/14/09

Abbott Seeks FDA Approval of New Dosage Strengths of SIMCOR
Abbott, 12/11/09

Recombinant Human Erythropoietin, Epogin Injection Application for Approval of Additional Indication of Chemotherapy-Induced Anemia
Chugai Pharmaceutical Co., 12/08/09

 See all of Drug/Product Approvals